This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

Register by January 24 to save up to $1200

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Ralf Eisenhuth, PhD
Principat Scientist at Bachem AG
Speaker

Profile

With a Ph. D. in organic chemistry from the University of Karlsruhe (KIT), Ralf Eisenhuth joined Bachem AG in 2008 as a team leader. Over the last two decades, he held several positions at Bachem; ranging from process development to leading of the large-scale purification department at Bachems main site in Bubendorf. In his current position as Principal Scientist, his focus is on innovative purification technologies and processes for oligonucleotides and peptides. In the recent years, he spend most of his time establishing Bachems capability for large scale MCSGP purification of oligonucleotides and peptides under GMP.

Agenda Sessions

  • Breaking with Traditions: Supporting Next Generation Peptide and Oligonucleotide Drugs with Intensified Processes

    2:45pm